论文部分内容阅读
目的探讨特布他林气雾剂联合肺力咳合剂治疗支气管哮喘患者的临床效果。方法选取2014年1-10月北票市中医院收治的104例支气管哮喘患者作为研究对象,按随机数字表法将其分为A组和B组,各52例。A组患者仅口服孟鲁司特钠片进行治疗,B组患者采用特布他林气雾剂及肺力咳合剂,比较两组患者的临床疗效、治疗前后呼气峰值流速(PEF)、用力肺活量(FVC)及血清肿瘤坏死因子-α(TNF-α)、白细胞介素6(IL-6)水平变化情况。结果 B组患者的总有效率明显高于A组,差异有统计学意义(P<0.05);治疗后,B组患者的PEF、FVC均明显高于对照组,血清IL-6、TNF-A水平均明显低于对照组,差异均有统计学意义(均P<0.05)。结论特布他林气雾剂联合肺力咳合剂治疗支气管哮喘患者临床效果明显,可明显改善患者的临床症状。
Objective To investigate the clinical effects of terbutaline and lung cough mixture in the treatment of patients with bronchial asthma. Methods A total of 104 patients with bronchial asthma admitted from Beipiao Hospital of Traditional Chinese Medicine from January to October 2014 were selected as the research objects. According to the random number table, they were divided into group A and group B, with 52 cases in each group. Patients in group A were treated with montelukast sodium tablets only. Patients in group B were treated with terbutaline aerosol and lung cough mixture. The clinical efficacy, peak expiratory flow (PEF) before and after treatment, (FVC) and serum levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) Results The total effective rate in group B was significantly higher than that in group A (P <0.05). After treatment, the PEF and FVC in group B were significantly higher than those in control group, and the levels of serum IL-6 and TNF-α The levels were significantly lower than the control group, the differences were statistically significant (P <0.05). Conclusion Terbutaline aerosol combined with lung cough mixture in the treatment of patients with bronchial asthma clinical effect is obvious, can significantly improve the clinical symptoms of patients.